These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26251330)

  • 1. Response.
    Goldstein D; Von Hoff D
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26251330
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic advances in pancreatic cancer: miles to go before we sleep.
    Bekaii-Saab T; Goldberg R
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25638250
    [No Abstract]   [Full Text] [Related]  

  • 3. RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.
    Palani Velu LK; Steele CW; Dickson EJ; Carter CR; McKay CJ; Horgan PG; McMillan DC; Jamieson NB
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26251329
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for pancreatic carcinoma.
    Kao GD
    Lancet; 1991 Jan; 337(8734):177. PubMed ID: 1670814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 7. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J
    Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
    Levy A; Chargari C; Huguet F; Védrine L; Deutsch E
    Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
    Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic salt dysgeusia.
    Marinella MA
    South Med J; 2008 Dec; 101(12):1275-6. PubMed ID: 19005446
    [No Abstract]   [Full Text] [Related]  

  • 14. UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
    Mani S
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):124-7. PubMed ID: 9348584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy following resection for pancreatic adenocarcinoma.
    Brennan MF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Atkins CD
    N Engl J Med; 2000 May; 342(20):1524-5; author reply 1526-7. PubMed ID: 10819649
    [No Abstract]   [Full Text] [Related]  

  • 19. Erlotinib and pancreatic adenocarcinoma: uncertainty and hope.
    Zoras O; Batsis C
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S246-7. PubMed ID: 21630121
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Conroy T; Marchal F; Briançon S
    N Engl J Med; 2000 May; 342(20):1525; author reply 1526-7. PubMed ID: 10819650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.